Guadecitabine
Drug timelines are a Plus or Pro feature.
13 regulatory and trial events tracked for Guadecitabine, covering 2020-01-31 to 2025-12-05. Get the full timeline:
Most recent: Clinical Trial Update: Guadecitabine and Durvalumab in Treating Patients With Advanced Liver, Pancreatic, Bile Duct, or Gallbladder Cancer [Phase 1]